Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ. Thomas Hutton, Jerry L. Morris, H. I. Hurtig et al.|Neurology|1996Cited by 89
Transdermal dopaminergic D<sub>2</sub> receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled studyJ. Thomas Hutton, Jerry L. Morris, Leo Verhagen Metman et al.|Movement Disorders|2001Cited by 60